Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian W Loggie

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|July 17, 2015
Gastrointestinal Cancers With Peritoneal Carcinomatosis: Surgery and Hyperthermic Intraperitoneal ChemotherapyBrian W Loggie, Peter Thomas
Molecular Cancer|December 11, 2002
The roles of sex steroid receptor coregulators in cancerXiuhua Gao, Brian W Loggie, Zafar Nawaz
Croatian Medical Journal|October 18, 2008
Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case reportZoran Gatalica, Jason M Foster, Brian W Loggie
The American Surgeon|September 11, 2002
Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignanciesPerry Shen, Aaron Hoffman, Russell Howerton, et al.
Plos One|June 23, 2017
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignanciesMurali R Kuracha, Peter Thomas, Brian W Loggie, et al.
Cancer Medicine|February 3, 2016
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironmentMurali R Kuracha, Peter Thomas, Brian W Loggie, et al.
Anticancer Research|February 26, 2004
Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude miceTeng-Fei Zhang, Shui-Qing Yu, Brian W Loggie, et al.
The American Surgeon|June 3, 2014
Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesotheliomaShreya J Shetty, Lokesh Bathla, Venkatesh Govindarajan, et al.
Annals of Surgical Oncology|November 11, 2008
Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesotheliomaJason M Foster, Zoran Gatalica, Stan Lilleberg, et al.
International Journal of Molecular Sciences|August 12, 2023
Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma CellsMurali R Kuracha, Venkatesh Govindarajan, Brian W Loggie, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|July 17, 2015
Gastrointestinal Cancers With Peritoneal Carcinomatosis: Surgery and Hyperthermic Intraperitoneal ChemotherapyBrian W Loggie, Peter Thomas
Molecular Cancer|December 11, 2002
The roles of sex steroid receptor coregulators in cancerXiuhua Gao, Brian W Loggie, Zafar Nawaz
Croatian Medical Journal|October 18, 2008
Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case reportZoran Gatalica, Jason M Foster, Brian W Loggie
The American Surgeon|September 11, 2002
Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignanciesPerry Shen, Aaron Hoffman, Russell Howerton, et al.
Plos One|June 23, 2017
Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignanciesMurali R Kuracha, Peter Thomas, Brian W Loggie, et al.
Cancer Medicine|February 3, 2016
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironmentMurali R Kuracha, Peter Thomas, Brian W Loggie, et al.
Anticancer Research|February 26, 2004
Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude miceTeng-Fei Zhang, Shui-Qing Yu, Brian W Loggie, et al.
The American Surgeon|June 3, 2014
Comparison of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with mitomycin or carboplatin for diffuse malignant peritoneal mesotheliomaShreya J Shetty, Lokesh Bathla, Venkatesh Govindarajan, et al.
Annals of Surgical Oncology|November 11, 2008
Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesotheliomaJason M Foster, Zoran Gatalica, Stan Lilleberg, et al.
International Journal of Molecular Sciences|August 12, 2023
Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma CellsMurali R Kuracha, Venkatesh Govindarajan, Brian W Loggie, et al.
Pageof 3